Cited by

• Inflammatory cell distribution in primary merkel cell carcinoma.

  Wheat R, Roberts C, Waterboer T, Steele J, Marsden J, Steven NM, Blackbourn DJ. Wheat R, et al. Cancers (Basel). 2014 May 6;6(2):1047-64. doi: 10.3390/cancers6021047. Cancers (Basel). 2014. PMID: 24961933 Free PMC article.
• Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma.

  Koljonen V, Kukko H, Pukkala E, Sankila R, Böhling T, Tukiainen E, Sihto H, Joensuu H. Koljonen V, et al. Br J Cancer. 2009 Oct 20;101(8):1444-7. doi: 10.1038/sj.bjc.6605306. Epub 2009 Sep 15. Br J Cancer. 2009. PMID: 19755994 Free PMC article.
• Microbial ecology of the skin in the era of metagenomics and molecular microbiology.

  Hannigan GD, Grice EA. Hannigan GD, et al. Cold Spring Harb Perspect Med. 2013 Dec 1;3(12):a015362. doi: 10.1101/cshperspect.a015362. Cold Spring Harb Perspect Med. 2013. PMID: 24296350 Free PMC article. Review.
• Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.

  Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS. Tolstov YL, et al. Int J Cancer. 2009 Sep 15;125(6):1250-6. doi: 10.1002/ijc.24509. Int J Cancer. 2009. PMID: 19499548 Free PMC article.
• Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.

  Paulson KG, Iyer JG, Blom A, Warton EM, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM, Nghiem P. Paulson KG, et al. J Invest Dermatol. 2013 Mar;133(3):642-646. doi: 10.1038/jid.2012.388. Epub 2012 Nov 29. J Invest Dermatol. 2013. PMID: 23190897 Free PMC article.